Abstract
Background: Caregivers of persons with Alzheimer’s Disease (AD) often experience feelings of lack of support and information from specialists when operating in real scenarios, inclusive of old-age psychiatric wards, care homes, community, and patient’s home.
Objective: AD caregivers can provide narrative about what issues need to be addressed in Ecological Momentary Assessment (EMA) to capture real-time and real-scenario needs in AD caregiving, and Ecological Momentary Interventions (EMI) as online e-learning to assist in areas of concerns.
Method: Twelve focus group discussions took place with AD caregivers for a total of 62 people interviewed. Once major themes in surveys and learning were identified by using discourse analysis, AD caregivers expressed the likelihood that these themes (where 0 meant “nil” and 1 meant “completely”) would address their focal needs in caregiving and topics in learning. Z scores for proportions and Cohen’s d effect size were calculated for each item reporting the averaged scores.
Results: AD caregivers indicated that the major areas of concern that could benefit from an EMA/EMI online platform were: support (d=3.08), collaboration (d=1.85), medication review (d=1.21), dealing with grief and mourning, and time (d=0.97). Moreover, they identified personal resources available to provide help to colleagues: support (d=1.34), information (d=0.97), collaboration (d=2.06), hospital admission (d=3.08), and hospital discharge (d=5.50).
Conclusion: Focus groups and narratives can be the initial stage in creating a dedicated AD app supporting EMA/EMI in AD care.
Keywords: Alzheimer`s disease, caregivers, e-learning, educational apps, ecological momentary assessment, ecological momentary intervention.
Current Alzheimer Research
Title:Ecological Momentary Assessments and Interventions in Alzheimer’s Caregiving
Volume: 15 Issue: 11
Author(s): Carlo Lazzari*
Affiliation:
- International Centre for Healthcare and Medical Education, King`s Wood Centre, Colchester CO45JY,United Kingdom
Keywords: Alzheimer`s disease, caregivers, e-learning, educational apps, ecological momentary assessment, ecological momentary intervention.
Abstract: Background: Caregivers of persons with Alzheimer’s Disease (AD) often experience feelings of lack of support and information from specialists when operating in real scenarios, inclusive of old-age psychiatric wards, care homes, community, and patient’s home.
Objective: AD caregivers can provide narrative about what issues need to be addressed in Ecological Momentary Assessment (EMA) to capture real-time and real-scenario needs in AD caregiving, and Ecological Momentary Interventions (EMI) as online e-learning to assist in areas of concerns.
Method: Twelve focus group discussions took place with AD caregivers for a total of 62 people interviewed. Once major themes in surveys and learning were identified by using discourse analysis, AD caregivers expressed the likelihood that these themes (where 0 meant “nil” and 1 meant “completely”) would address their focal needs in caregiving and topics in learning. Z scores for proportions and Cohen’s d effect size were calculated for each item reporting the averaged scores.
Results: AD caregivers indicated that the major areas of concern that could benefit from an EMA/EMI online platform were: support (d=3.08), collaboration (d=1.85), medication review (d=1.21), dealing with grief and mourning, and time (d=0.97). Moreover, they identified personal resources available to provide help to colleagues: support (d=1.34), information (d=0.97), collaboration (d=2.06), hospital admission (d=3.08), and hospital discharge (d=5.50).
Conclusion: Focus groups and narratives can be the initial stage in creating a dedicated AD app supporting EMA/EMI in AD care.
Export Options
About this article
Cite this article as:
Lazzari Carlo *, Ecological Momentary Assessments and Interventions in Alzheimer’s Caregiving, Current Alzheimer Research 2018; 15 (11) . https://dx.doi.org/10.2174/1567205015666180702111523
DOI https://dx.doi.org/10.2174/1567205015666180702111523 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Autologus Stem Cell Transplatation as a Care Option in Elderly Patients. A Review
Anti-Cancer Agents in Medicinal Chemistry CD14-Dependent Innate Immunity-Mediated Neuronal Damage in Vivo is Suppressed by NSAIDs and Ablation of a Prostaglandin E2 Receptor, EP2
Current Medicinal Chemistry - Central Nervous System Agents Influence of Lithium Treatment on GDNF Serum and CSF Concentrations in Patients with Early Alzheimers Disease
Current Alzheimer Research Review of the Syntheses and Activities of Some Sulfur-Containing Drugs
Current Organic Synthesis Concepts for Biologically Active Peptides
Current Pharmaceutical Design Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line
Current Drug Delivery One Hundred Faces of Cyclopamine
Current Pharmaceutical Design Improving the Utility of Steroidal Anti-Inflammatories: Identification of Selective Glucocorticoid Receptor Modulators
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Chronic Inflammatory Disorders and Accelerated Atherosclerosis: Chronic Kidney Disease
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Alzheimer Research Target Therapies in Pancreatic Carcinoma
Current Medicinal Chemistry Healing the Heart with Sirtuins and Mammalian Forkhead Transcription Factors
Current Neurovascular Research Pharmacological Therapy in Children with Atrioventricular Reentry: Which Drug?
Current Pharmaceutical Design Hydrogen Sulfide: A New Tool to Design and Develop Drugs
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Variability in the Response to Non-pharmacological Treatments in Patients with Cardiovascular Diseases
Current Pharmacogenomics and Personalized Medicine Substance Use Disorder Related to Kratom (Mitragyna speciosa) Use in Malaysia
Current Psychopharmacology Hyperpolarized Metabolic MR in the Study of Cardiac Function and Disease
Current Pharmaceutical Design Design of Sphingosine Kinases Inhibitors: Challenges and Recent Developments
Current Pharmaceutical Design Intracranial Venous Haemodynamics in Multiple Sclerosis
Current Neurovascular Research The Impact of Phytosterols on the Healthy and Diseased Brain
Current Medicinal Chemistry